|
Wisconsin Pharmaceutical Research & Development News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about Wisconsin Pharmaceuticals.
Latest Wisconsin Pharmaceutical Research & Development News
- Medical College of Wisconsin: Transcendental Meditation helped heart disease patients lower cardiac disease risks by 50 percent 3 Dec 2009 05:30 GMT
... was conducted at The Medical College of Wisconsin in Milwaukee in collaboration with the Institute ... Center for Natural Medicine and Prevention, "Previous research on Transcendental Meditation has shown reductions in ... are derived from the body's own internal pharmacy stimulated by the Transcendental Meditation practice," he said. ...
- Wisconsin to create electronic medical records exchange 1 Dec 2009 20:30 GMT
... the security image above: The state of Wisconsin will develop an electronic medical records exchange by June ... consumer organization, hospitals, physicians, the business community, pharmacies, laboratories, higher education, quality/health organizations, public health, ...
- Wisconsin creates HIE planning committee 2 Dec 2009 15:50 GMT
... has been created by the state of Wisconsin to develop a statewide health information exchange that is ... consumer organization, hospitals, physicians, the business community, pharmacies, laboratories, higher education, quality/health organizations, public health, ...
- www.StockMarketingInc.com: If You Haven't Signed Up Yet Do It Now!! SNWT,NPHC,OMCL,OTPR,SIAL,SQNM 3 Dec 2009 16:04 GMT
... SNWT) San West, Inc., (OTCBB: NPHC) Nutra Pharma Corp., (NASDAQ: OMCL) Omnicell, Inc., (NASDAQ: OPTR) Optimer Pharmaceuticals, ... (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple ... its subsidiaries carries out basic drug discovery research and clinical development and also seeks strategic ...
- VELCADE (Bortezomib) for Injection to be Featured in Plenary Session at American Society of Hematology 30 Nov 2009 20:40 GMT
... are excited by the breadth of ongoing research being presented at this year's ASH meeting ... Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, ... proteasome inhibitor, and has a robust clinical development pipeline of product candidates. Millennium Pharmaceuticals, Inc. ...
- VELCADE® (Bortezomib) for Injection to be Featured in Plenary Session at American Society of Hematology 30 Nov 2009 20:41 GMT
... are excited by the breadth of ongoing research being presented at this year's ASH meeting ... Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, ... proteasome inhibitor, and has a robust clinical development pipeline of product candidates. Millennium Pharmaceuticals, Inc. ...
- VELCADE(R) (Bortezomib) for Injection to be Featured in Plenary Session at American Society of Hematology 30 Nov 2009 21:01 GMT
... are excited by the breadth of ongoing research being presented at this year's ASH meeting ... Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, ... proteasome inhibitor, and has a robust clinical development pipeline of product candidates. Millennium Pharmaceuticals, Inc. ...
- www.PicksThatMove.com: "Picks that move" Alerts, December 03, 2009: ICOC, CCRT, GNBT, UTIW and DNR 3 Dec 2009 19:33 GMT
... Generex (NASDAQ: GNBT) is engaged in the research, development and commercialization of drug delivery systems and ... unique supply chain requirements such as the pharmaceutical, retail, apparel, chemical, automotive and technology industries. ...
- PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, December 03, 2009: ICOC, CCRT, GNBT, UTIW and DNR 3 Dec 2009 20:21 GMT
... Generex (NASDAQ: GNBT) is engaged in the research, development and commercialization of drug delivery systems and ... unique supply chain requirements such as the pharmaceutical, retail, apparel, chemical, automotive and technology industries. ...
- Questioning a $30,000-a-Month Cancer Drug 5 Dec 2009 11:52 GMT
... not being a backlash against the pricing.” Drug makers in general have been raising prices sharply ... saying it made a significant investment to develop the first approved drug for this type ... the drug is given more frequently. Gloucester Pharmaceuticals, which won approval in November for a ...
- Executive QandA with Curt Mueller: Growing a business from the ground up 7 Dec 2009 05:14 GMT
... Dec 06, 2009 (The Wisconsin State Journal - McClatchy-Tribune Information Services via ... has continually adjusted with the times and developed new products to become a worldwide player ... began in the basement of his father's pharmacy in downtown Prairie du Sac. The former ...
- Executive Q&A with Curt Mueller: Growing a business from the ground up 6 Dec 2009 11:34 GMT
... has continually adjusted with the times and developed new products to become a worldwide player ... began in the basement of his father's pharmacy in downtown Prairie du Sac. The former ... of selling to the high schools in Wisconsin, I had a chance to meet Ewing ...
- Durand illustrates small-town struggles: In a rapidly world, and other face the of forging a newfuture while still their 6 Dec 2009 16:33 GMT
... contrast, the population climbed 27 percent in Wisconsin and 50 percent in the United States ... Gerald Bauer said, citing several recent economic development successes such as construction of a new ... so," said Bob Heike, owner of Heike Pharmacy in downtown Durand. "For this generation, travel ...
- 'Sharing Miracles' Television Program to Feature Three-Time Super Bowl Champion Tedy Bruschi 2 Dec 2009 15:43 GMT
... his recovery to the persistence that he developed growing up in football: "I was always ... offered by biologic medicines. In fact, America's pharmaceutical research companies currently have more than 300 new ...
- 'Sharing Miracles' Television Program to Feature Three-Time Super Bowl Champion Tedy Bruschi 2 Dec 2009 15:50 GMT
... his recovery to the persistence that he developed growing up in football: "I was always ... offered by biologic medicines. In fact, America's pharmaceutical research companies currently have more than 300 new ...
Powered by 
Wisconsin Pharmaceuticals News Sections
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Pharmaceutical Industry Today
|
a digital news provider
ap.org:
cnn.com:
bbc.co.uk:
healthday.com: